The role of PET in first-line treatment of Hodgkin lymphoma - The Lancet Haematology
![Cancers | Free Full-Text | Is There a Role for [18F]FDG PET-CT in Staging MALT Lymphoma?](https://pub.mdpi-res.com/cancers/cancers-14-00750/article_deploy/html/images/cancers-14-00750-g001.png?1644317383 "Cancers | Free Full-Text | Is There a Role for [18F]FDG PET-CT in Staging MALT Lymphoma?")
Cancers | Free Full-Text | Is There a Role for [18F]FDG PET-CT in Staging MALT Lymphoma?
FDG PET for therapy monitoring in Hodgkin and non-Hodgkin lymphomas | SpringerLink
Cureus | Diagnostic Yield of FDG-PET/CT, MRI, and CSF Cytology in Non-Biopsiable Neurolymphomatosis as a Heralding Sign of Recurrent Non-Hodgkin's Lymphoma | Article
FDG‐PET/CT in the management of lymphomas: current status and future directions - El‐Galaly - 2018 - Journal of Internal Medicine - Wiley Online Library
Biomedicines | Free Full-Text | Radiotherapy in Follicular Lymphoma Staged by 18F-FDG-PET/CT: A German Monocenter Study
Frontiers | The Clinical Accuracy and Risk Stratification in End of Therapy 18F-FDG PET/CT in Burkitt Lymphoma
PET/MRI an effective alternative to PET/CT for lymphoma management
Follow-up PET/CT Altering Patient Management for Non-Hodgkin Lymphoma | Imaging Technology News
PET/CT for Therapy Response Assessment in Lymphoma | Journal of Nuclear Medicine
Pet Scan - Lymphoma Australia
Interim FDG-PET/CT for therapy monitoring and prognostication in Hodgkin's Lymphoma | Scientific Reports
Comparison of whole-body diffusion-weighted magnetic resonance and FDG-PET/ CT in the assessment of Hodgkin's lymphoma for staging and treatment response - ecanc
18F-FDG PET/CT for Monitoring the Response of Lymphoma to Radioimmunotherapy | Journal of Nuclear Medicine
The role of PET in the first-line treatment of the most common subtypes of non-Hodgkin lymphoma - The Lancet Haematology
PET-CT of leukemic-lymphomatous muscle ınfiltration
Frontiers | Imaging Lymphoma With F-18 Fluorodeoxyglucose PET-CT: What Should Be Known About Normal Variants, Pitfalls, and Artifacts?
Non-Hodgkin's lymphoma, CT and PET scans - Stock Image - M134/0688 - Science Photo Library
Diagnostic value of baseline 18FDG PET/CT skeletal textural features in follicular lymphoma | Scientific Reports
FDG‐PET/CT in the management of lymphomas: current status and future directions - El‐Galaly - 2018 - Journal of Internal Medicine - Wiley Online Library
Understanding the role of PET CT in lymphoma management: The era of Lugano Classification | Journal of Nuclear Medicine
![Preliminary evidence of imaging of chemokine receptor-4-targeted PET/CT with [68Ga]pentixafor in non-Hodgkin lymphoma: comparison to [18F]FDG | EJNMMI Research | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13550-020-00681-7/MediaObjects/13550_2020_681_Fig1_HTML.png "Preliminary evidence of imaging of chemokine receptor-4-targeted PET/CT with [68Ga]pentixafor in non-Hodgkin lymphoma: comparison to [18F]FDG | EJNMMI Research | Full Text")
Preliminary evidence of imaging of chemokine receptor-4-targeted PET/CT with [68Ga]pentixafor in non-Hodgkin lymphoma: comparison to [18F]FDG | EJNMMI Research | Full Text
RESISTing the Need to Quantify: Putting Qualitative FDG-PET/CT Tumor Response Assessment Criteria into Daily Practice | American Journal of Neuroradiology
